Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs

Injury

Volumn 41, Issue 7, 2010, Pages 717-723

  Hakimi, M ^a   Jungbluth, P ^a   Sager, M ^a   Betsch, M ^a   Herten, M ^a   Becker, J ^a   Windolf, J ^a   Wild, M ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Animal model; Bone defect; Bone healing; Growth factors; Mini pig; Platelet rich plasma

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE DEFECT; BONE RADIOGRAPHY; BONE REGENERATION; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FRACTURE HEALING; HISTOPATHOLOGY; LONG BONE; METAPHYSICS; MINIPIG; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THROMBOCYTE; THROMBOCYTE RICH PLASMA; TIBIA;

EID: 77957165341     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2009.12.005     Document Type: Article

References (35)

1. Aghaloo TL, Moy PK, Freymiller EG. Investigation of platelet-rich plasma in rabbit cranial defects: a pilot study. J Oral Maxillofac Surg 2002;60:1176-81.
2. Antoniades HN. Human platelet-derived growth factor (PDGF): purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc Natl Acad Sci USA 1981;78:7314-7.
3. Beck LS, DeGuzman L, Lee WP, et al. One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest 1993;92:2841-9.
4. Bowen-Pope DF, Vogel A, Ross R Production of platelet-derived growth factorlike molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci USA 1984;81:2396-400.
5. Camargo PM, Lekovic V, Weinlaender M, et al. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res 2002;37:300-6.
6. Dallari D, Savarino L, Stagni C, et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 2007;89:2413-20.
7. de Vasconcelos Gurgel BC, Goncalves PF, Pimentel SP, et al. Platelet-rich plasma may not provide any additional effect when associated with guided bone regeneration around dental implants in dogs. Clin Oral Implants Res 2007;18:649-54.
8. Donath K. The diagnostic value of the new method for the study of undecalcified bones and teeth with attached soft tissue (Sage-Schliff (sawing and grinding) technique). Pathol Res Pract 1985;179:631-3.
9. Friedlaender GE. Osteogenic protein-1 in treatment of tibial nonunions: current status. SurgTechnol Int 2004;13:249-52.
10. Fuerst G, Gruber R, Tangi S, et al. Effects of fibrin sealant protein concentrate with and without platelet-released growth factors on bony healing of cortical mandibular defects. An experimental study in minipigs. Clin Oral Implants Res 2004;15:301-7.
11. Fuerst G, Reinhard G, Tangl S, et al. Effect of platelet-released growth factors and collagen type I on osseous regeneration of mandibular defects. A pilot study in minipigs. J Clin Periodontol 2004:31:784-90.
12. Garg AK The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent lmplantol Update 2000;11:17-21.
13. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury 2005;36(Suppl. 3):S20-27.
14. Govender S, Csimma C, Genant HK et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84-A:2123-34.
15. Jensen TB, Rahbek O, Overgaard S, Soballe K. Platelet rich plasma and fresh frozen bone allograft as enhancement of implant fixation. An experimental study in dogs. J Orthop Res 2004;22:653-8.
16. Kitoh H, Kitakoji T, Tsuchiya H, et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis - a preliminary result of three cases. Bone 2004;35:892-8.
17. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesiseffect of oxygen gradients and inspired oxygen concentration. Surgery 1981;90:262-70.
18. Mahendra A, Maclean AD. Available biological treatments for complex nonunions. Injury 2007;38(Suppl. 4):S7-12.
19. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004;62:489-96.
20. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-46.
21. Marx RE, Ehler WJ, Peleg M. "Mandibular and facial reconstruction" rehabilitation of the head and neck cancer patient. Bone 1996;19:59S-82S.
22. Miyazono K, Heldin CH. The mechanism of action of transforming growth factor-beta. Gastroenterol Jpn 1993;28(Suppl. 4):81-5 [discussion 86-7].
23. Mohan S, Baylink DJ. Bone growth factors. Clin Orthop Relat Res 1991:30-48.
24. Pierce GF, Tarpley JE, Yanagihara D, et al. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol 1992;140:1375-88.
25. Sarkar MR, Augat P, Shefelbine SJ, et al. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials 2006:27:1817-23.
26. Schieker M, Heiss C, Mutschler W. Bone substitutes. Unfallchirurg 2008:111: 613-9 [quiz 620].
27. Schlegel KA, Kloss FR, Schultze-Mosgau S, et al. Osseous defect regeneration using autogenous bone alone or combined with Biogran or Algipore with and without added thrombocytes. A microradiologic evaluation. Mund Kiefer Gesichtschir 2003;7:112-8.
28. Schwarz F, Herten M, Ferrari D, et al. Guided bone regeneration at dehiscencetype defects using biphasic hydroxyapatite + beta tricalcium phosphate (Bone Ceramic) or a collagen-coated natural bone mineral (BioOss Collagen): an immunohistochemical study in dogs. Int J Oral Maxillofac Surg 2007;36: 1198-206.
29. Singh JP, Chaikin MA, Stiles CD. Phylogenetic analysis of platelet-derived growth factor by radio-receptor assay. J Cell Biol 1982;95:667-71.
30. Thor A, Franke-Stenport V, Johansson CB, Rasmusson L. Early bone formation in human bone grafts treated with platelet-rich plasma: preliminary histomorphometric results. Int J Oral Maxillofac Surg 2007;36:1164-71.
31. Veillette CJ, McKee MD. Growth factors-BMPs, DBMs, and buffy coat products: are there any proven differences amongst them? Injury 2007;38(Suppl. 1 ):S38-48.
32. Weibrich G, Gnoth SH, Otto M, et al. Growth stimulation of human osteoblastlike cells by thrombocyte concentrates in vitro. Mund Kiefer Gesichtschir 2002;6:168-74.
33. Wheeler DL, Cross AR, Eschbach EJ, et al. Grafting of massive tibial subchondral bone defects in a caprine model using beta-tricalcium phosphate versus autograft. J Orthop Trauma 2005;19:85-91.
34. Wrotniak M, Bielecki T, Gazdzik TS. Current opinion about using the plateletrich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil 2007;9:227-38.
35. Zimmermann G, Moghaddam A, Wagner C, et al. Clinical experience with bone morphogenetic protein 7 (BMP 7) in nonunions of long bones. Unfallchirurg 2006;109:528-37.